Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis

被引:14
作者
Lee, Ji-Hyun [1 ]
Choi, Young-Jin [1 ]
Heo, Sun-Hee [1 ]
Lee, Jae-Mok [2 ]
Cho, Je-Yoel [1 ]
机构
[1] Kyungpook Natl Univ, Sch Dent, Dept Biochem, Taegu 700422, South Korea
[2] Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Taegu 700422, South Korea
关键词
GCF; OPG; Periodontal disease; RANKL; TACE; GINGIVAL CREVICULAR FLUID; PORPHYROMONAS-GINGIVALIS; CELLS; DISEASES; INTERLEUKIN-6; PROTEASE; FAMILY; OPG;
D O I
10.5483/BMBRep.2011.44.7.473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Periodontitis is a very prevalent disease. Therefore, biomarkers for the early and standard diagnoses of periodontitis are urgently needed. TACE is a membrane-bound metalloprotease. Although a recent study suggested that TACE levels in GCF are elevated during periodontal disease, the levels of TACE in GCF at different stages of chronic periodontitis have not been determined. Here, we analyzed the protein levels of TACE in GCF from periodontal disease subjects and confirmed that the protein levels of TACE were higher in the moderate periodontitis groups. TACE is known to be a NF-kappa B ligand that stimulates RANKL secretion in osteoblasts. To understand the effects of TACE on RANKL and OPG in osteoblasts, we treated MG63 cells with TACE. We observed an increase in RANKL protein expression but a decrease in OPG protein expression. Our data suggest that TACE can induce RANKL expression and promote osteoclastogenesis, thus worsening the outcome of periodontitis. [BMB reports 2011; 44(7): 473-477]
引用
收藏
页码:473 / 477
页数:5
相关论文
共 43 条
  • [1] Tumor necrosis factor-α-converting enzyme (TACE) levels in periodontal diseases
    Bostanci, N.
    Emingil, G.
    Afacan, B.
    Han, B.
    Ilgenli, T.
    Atilla, G.
    Hughes, F. J.
    Belibasakis, G. N.
    JOURNAL OF DENTAL RESEARCH, 2008, 87 (03) : 273 - 277
  • [2] Heterocyclic inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Levin, Jeremy I.
    HETEROCYCLES, 2006, 70 : 691 - +
  • [3] Tumor necrosis factor-α converting enzyme
    Black, RA
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (01) : 1 - 5
  • [4] Structure and functions of tumor necrosis factor-α converting enzyme
    Mezyk, R
    Bzowska, M
    Bereta, J
    ACTA BIOCHIMICA POLONICA, 2003, 50 (03) : 625 - 645
  • [5] Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis
    Kim, Ji-Hye
    Kim, Ae Ri
    Choi, Yun Hui
    Jong, Sungil
    Woo, Gye-Hyeong
    Cha, Jeong-Heon
    Bak, Eun-Jung
    Yoo, Yun-Jung
    PLOS ONE, 2017, 12 (12):
  • [6] Regulation of tumor necrosis factor-α and tumor necrosis factor converting enzyme in human osteoarthritis
    Amin, AR
    OSTEOARTHRITIS AND CARTILAGE, 1999, 7 (04) : 392 - 394
  • [7] Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-α converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma
    Ringel, Joerg
    Jesnowski, Ralf
    Moniaux, Nicolas
    Luettges, Jutta
    Ringel, Jens
    Choudhury, Amit
    Batra, Surinder K.
    Kloeppel, Guenter
    Loehr, Matthias
    CANCER RESEARCH, 2006, 66 (18) : 9045 - 9053
  • [8] Niaspan treatment increases tumor necrosis factor-α-converting enzyme and promotes arteriogenesis after stroke
    Chen, Jieli
    Cui, Xu
    Zacharek, Alex
    Ding, Guang Liang
    Shehadah, Amjad
    Jiang, Quan
    Lu, Mei
    Chopp, Michael
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 (05) : 911 - 920
  • [9] Discovery of novel hydantoins as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Sheppeck, James E., II
    Gilmore, John L.
    Yang, Anle
    Chen, Xiao-Tao
    Xue, Chu-Biao
    Roderick, John
    Liu, Rui-Qin
    Covington, Maryanne B.
    Decicco, Carl P.
    Duan, James J. -W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1413 - 1417
  • [10] Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-α converting enzyme (TACE)
    Sheppeck, James E., II
    Gilmore, John L.
    Tebben, Andrew
    Xue, Chu-Biao
    Liu, Ru-Qin
    Decieco, Carl P.
    Duan, James J. -W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (10) : 2769 - 2774